SEI Investments’s Genocea Biosciences, Inc. GNCA Stock Holding History

SEI Investments’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-42	Closed	–	–	3918
2018 Q1	$0	Hold	42	–	–	﹤0.01%	3785
2017 Q4	$0	Buy	+42	New	+$422	﹤0.01%	3602

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SEI Investments's GNCA Position: Q2 2018 in Review

SEI Investments sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2018, closing a stake of 42 shares.

SEI Investments first reported a position in GNCA in Q4 2017 and held it in 2 quarters. The position peaked at $0 in Q1 2018. 54 funds tracked by Wall St. Rank hold GNCA as of Q2 2018.

SEI Investments reported no remaining Genocea Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
SEI Investments sold 42 Genocea Biosciences, Inc. shares in Q2 2018.
SEI Investments first reported a position in Genocea Biosciences, Inc. in Q4 2017 and held it in 2 quarters.
SEI Investments's Genocea Biosciences, Inc. position peaked at $0 in Q1 2018.
54 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2018.

Based on SEI Investments's 13F filing for Q2 2018, filed 3 Aug 2018.